Board of Scientific Counselors, Coordinating Center for Health Promotion (BSC, CCHP or the BSC), 44857-44858 [E9-20898]

Download as PDF cprice-sewell on DSK2BSOYB1PROD with NOTICES Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices 8989/800–433–3823. (Formerly: Laboratory Specialists, Inc.) Kroll Laboratory Specialists, Inc., 450 Southlake Blvd., Richmond, VA 23236. 804–378–9130. (Formerly: Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.) Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040. 713–856–8288/800–800–2387. Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869. 908–526– 2400/800–437–4986. (Formerly: Roche Biomedical Laboratories, Inc.) Laboratory Corporation of America Holdings, 1904 Alexander Drive, Research Triangle Park, NC 27709. 919–572–6900/800–833– 3984. (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group.) Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671. 866–827–8042/800–233–6339. (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center.) LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219. 913–888– 3927/800–873–8845. (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.) Maxxam Analytics,* 6740 Campobello Road, Mississauga, ON, Canada L5N 2L8. 905– 817–5700. (Formerly: Maxxam Analytics Inc., NOVAMANN (Ontario), Inc.) MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112. 651–636– 7466/800–832–3244. MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 97232. 503– 413–5295/800–950–5295. Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417. 612–725– 2088. National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304. 661–322–4250/800–350–3515. One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, TX 77504. 888–747–3774. (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory.) Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311. 800–328– 6942. (Formerly: Centinela Hospital Airport Toxicology Laboratory.) Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, WA 99204. 509–755–8991/800–541–7891x7. Phamatech, Inc., 10151 Barnes Canyon Road, San Diego, CA 92121. 858–643–5555. Quest Diagnostics Incorporated, 3175 Presidential Dr., Atlanta, GA 30340. 770– 452–1590/800–729–6432. (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories.) Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403. 610–631– 4600/877–642–2216. (Formerly: VerDate Nov<24>2008 14:57 Aug 28, 2009 Jkt 217001 SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories.) Quest Diagnostics Incorporated, 7600 Tyrone Ave., Van Nuys, CA 91405. 866–370–6699/ 818–989–2521. (Formerly: SmithKline Beecham Clinical Laboratories.) S.E.D. Medical Laboratories, 5601 Office Blvd., Albuquerque, NM 87109. 505–727– 6300/800–999–5227. South Bend Medical Foundation, Inc., 530 N. Lafayette Blvd., South Bend, IN 46601. 574–234–4176 x276. Southwest Laboratories, 4625 E. Cotton Center Boulevard, Suite 177, Phoenix, AZ 85040. 602–438–8507/800–279–0027. St. Anthony Hospital Toxicology Laboratory, 1000 N. Lee St., Oklahoma City, OK 73101. 405–272–7052. STERLING Reference Laboratories, 2617 East L Street, Tacoma, Washington 98421. 800– 442–0438. Toxicology & Drug Monitoring Laboratory, University of Missouri Hospital & Clinics, 301 Business Loop 70 West, Suite 208, Columbia, MO 65203. 573–882–1273. Toxicology Testing Service, Inc., 5426 NW. 79th Ave., Miami, FL 33166. 305–593– 2260. U.S. Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755–5235. 301–677–7085. * The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS’ NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on April 13, 2004 (69 FR 19644). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Elaine Parry, Director, Office of Program Services, SAMHSA. [FR Doc. E9–20932 Filed 8–28–09; 8:45 am] BILLING CODE 4162–20–P PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 44857 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Coordinating Center for Health Promotion (BSC, CCHP or the BSC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Time and Date: 1 p.m.–5 p.m., September 15, 2009. The call may end before 5 p.m. if business is completed. Someone will remain on the line until that time to notify callers that the call is ended and business complete. Place: Teleconference originating from CDC, 1825 Century Boulevard, NE., Room 4066, Atlanta, Georgia 30345. Call-in number: (800) 779–9076. Participant pass code: 39780. If you have a problem in accessing the call, call (404) 498–6700. Status: This meeting is open to the public via the conference line above which will accommodate approximately 100 callers. Purpose: This BSC is charged with providing advice and guidance to the Secretary of Health and Human Services, the Director of CDC, and the Director of CCHP concerning strategies and goals for the programs and research within the National Center on Birth Defects and Developmental Disabilities and the National Center for Chronic Disease Prevention and Health Promotion. Matters To Be Discussed: The agenda will include a continuation of the discussion and finalization of recommendations to CDC leadership as prescribed in the Coordinating Center for Health Promotion Charter. Those recommendations relate to strategic planning for the National Center on Birth Defects and Developmental Disabilities as well as the results of the BSC’s review of the National Center for Chronic Disease Prevention and Health Promotion as an organizational unit at CDC. Providing Oral or Written Comments: It is the policy of the BSC, CCHP to provide a brief period for oral public comments. In general, each individual or group requesting to make an oral presentation will be limited to a total time of five minutes, if time permits. Contact Person for Additional Information: Karen Steinberg, PhD, Senior Science Officer, Coordinating Center for Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop E– 70, Atlanta, Georgia 30341; telephone (404) 498–6700; fax (404) 498–6880; or via e-mail at Karen.Steinberg@cdc.hhs.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\31AUN1.SGM 31AUN1 44858 Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices Dated: August 25, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–20898 Filed 8–28–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Research Resources; Notice of Closed Meetings cprice-sewell on DSK2BSOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Special Emphasis Panel; ARRA STRB October Meeting 1. Date: October 6–9, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Mohan Viswanathan, PhD, Scientific Review Officer, National Center for Research Resources, National Institutes of Health, One Democracy Plaza, 6701 Democracy Blvd., Room 1084, Bethesda, MD 20892–4874, 301–435–0829, mv10f@nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; ARRA STRB October Meeting 2. Date: October 6–9, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Mohan Viswanathan, PhD, Scientific Review Officer, National Center for Research Resources, National Institutes of Health, One Democracy Plaza, 6701 Democracy Blvd., Room 1084, Bethesda, MD 20892–4874, 301–435–0829, mv10f@nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; ARRA STRB October Meeting 3. Date: October 6–9, 2009. Time: 8 a.m. to 5 p.m. VerDate Nov<24>2008 14:57 Aug 28, 2009 Jkt 217001 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Carol Lambert, PhD, Scientific Review Officer, Office of Review, National Institutes of Health, NCRR, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1076, MSC 4874, Bethesda, MD 20892 (301)– 435–0814, lambert@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; ARRA STRB October Meeting 4. Date: October 6–9, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Carol Lambert, PhD, Scientific Review Officer, Office of Review, National Institutes of Health, NCRR, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1076, MSC 4874, Bethesda, MD 20892, (301)– 435–0814, lambert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333; 93.702, ARRA Related Construction Awards, National Institutes of Health, HHS) Dated: August 24, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–20871 Filed 8–28–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Initial Review Group, Interventions Committee for Disorders Involving Children and Their Families. PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 Date: October 5–6, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC 20036. Contact Person: David I. Sommers, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Room 6154, MSC 9609, Bethesda, MD 20892–9606. 301–443–7861. dsommers@mail.nih.gov. Name of Committee: National Institute of Mental Health Initial Review Group, Interventions Committee for Adult Disorders. Date: October 13–14, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC 20036. Contact Person: David I. Sommers, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Room 6154, MSC 9606, Bethesda, MD 20892–9606. 301–443–7861. dsommers@mail.nih.gov. Name of Committee: National Institute of Mental Health Initial Review Group, Mental Health Services in Non-Specialty Settings. Date: October 13, 2009. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Washington, DC 20037. Contact Person: Aileen Schulte, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140, MSC 9608, Bethesda, MD 20892–9608. 301–443–1225. aschulte@mail.nih.gov. Name of Committee: National Institute of Mental Health Initial Review Group, Mental Health Services in MH Specialty Settings. Date: October 15, 2009. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC 20036. Contact Person: Marina Broitman, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6153, MSC 9608, Bethesda, MD 20892–9608. 301–402–8152. mbroitma@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: August 24, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–20873 Filed 8–28–09; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 74, Number 167 (Monday, August 31, 2009)]
[Notices]
[Pages 44857-44858]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20898]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Coordinating Center for Health 
Promotion (BSC, CCHP or the BSC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Time and Date: 1 p.m.-5 p.m., September 15, 2009.
    The call may end before 5 p.m. if business is completed. Someone 
will remain on the line until that time to notify callers that the 
call is ended and business complete.
    Place: Teleconference originating from CDC, 1825 Century 
Boulevard, NE., Room 4066, Atlanta, Georgia 30345.
    Call-in number: (800) 779-9076.
    Participant pass code: 39780.
    If you have a problem in accessing the call, call (404) 498-
6700.
    Status: This meeting is open to the public via the conference 
line above which will accommodate approximately 100 callers.
    Purpose: This BSC is charged with providing advice and guidance 
to the Secretary of Health and Human Services, the Director of CDC, 
and the Director of CCHP concerning strategies and goals for the 
programs and research within the National Center on Birth Defects 
and Developmental Disabilities and the National Center for Chronic 
Disease Prevention and Health Promotion.
    Matters To Be Discussed: The agenda will include a continuation 
of the discussion and finalization of recommendations to CDC 
leadership as prescribed in the Coordinating Center for Health 
Promotion Charter. Those recommendations relate to strategic 
planning for the National Center on Birth Defects and Developmental 
Disabilities as well as the results of the BSC's review of the 
National Center for Chronic Disease Prevention and Health Promotion 
as an organizational unit at CDC.
    Providing Oral or Written Comments: It is the policy of the BSC, 
CCHP to provide a brief period for oral public comments. In general, 
each individual or group requesting to make an oral presentation 
will be limited to a total time of five minutes, if time permits.
    Contact Person for Additional Information: Karen Steinberg, PhD, 
Senior Science Officer, Coordinating Center for Health Promotion, 
CDC, 4770 Buford Highway, NE., Mailstop E-70, Atlanta, Georgia 
30341; telephone (404) 498-6700; fax (404) 498-6880; or via e-mail 
at Karen.Steinberg@cdc.hhs.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for CDC and the Agency for Toxic Substances and Disease 
Registry.


[[Page 44858]]


    Dated: August 25, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-20898 Filed 8-28-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.